Balaxi Pharmaceuticals Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 16.50 | 23.61 | 26.22 |
| Operating Expense | 16.58 | 22.17 | 23.21 |
| Net Profit | -1.25 | 0.16 | 1.53 |
| Net Profit Margin | -7.58% | 0.68% | 5.84% |
| Earning Per Share | -0.23 | 0.03 | 0.28 |
| EBIDTA | -0.21 | 0.97 | 3.00 |
| Effective Tax Rate | -0% | -14.58% | 19.60% |
Particulars
Jun 2026
Revenue16.50
Operating Expense16.58
Net Profit-1.25
Net Profit Margin-7.58
Earning Per Share-0.23
EBIDTA-0.21
Effective Tax Rate-0
